EMCURE PHARMACEUTICALS
|
The Current P/S Ratio of EMCURE PHARMACEUTICALS is 3.80.
| Share Price | ₹1,938.7 | Oct 05,2026 |
| Market Cap | ₹36,776.2 Cr | |
| Sales-TTM | ₹9,683.5 Cr | TTM-Consolidated Results |
| Price/Sales | 3.80x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of EMCURE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹36,776.2 Cr] as on Oct 05,2026
(/) Sales [ ₹9,683.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.80x ]
Thus, for EMCURE PHARMACEUTICALS , the investors are currently willing to pay '3.80 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of EMCURE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of EMCURE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of EMCURE PHARMACEUTICALS
PS Ratio Performance Analysis for EMCURE PHARMACEUTICALS
- EMCURE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.17x.
- EMCURE PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, EMCURE PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 3.29x.
- EMCURE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does EMCURE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| EMCURE PHARMACEUTICALS | 9,683.5 | 3.80 | 36,776.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.14 | 427,562.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.78 | 244,572.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.50 | 180,871.0 |
| CIPLA LTD | 28,324.4 | 3.80 | 107,770.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.03 | 100,829.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.95 | 102,433.0 |
| LUPIN LTD | 29,966.6 | 3.07 | 91,915.3 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.97 | 113,566.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.75 | 96,088.1 |
| LAURUS LABS LTD | 7,269.6 | 14.60 | 106,117.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs EMCURE PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.75x |
| Max industry PS | 21.78x |
| Median industry PS | 3.97x |
| Average industry PS | 7.49x |
You may also like the below Video Courses